[
  {
    "title": "Bristol-Myers Squibb Company (NYSE:BMY) Stock is Plummeting, Here is Why - The Oracle Dispatch",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Bristol-Myers Squibb Company (NYSE:BMY) Stock is Plummeting, Here is Why - The Oracle Dispatch"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://oracledispatch.com/2020/10/07/bristol-myers-squibb-company-nysebmy-stock-is-plummeting-here-is-why/"
      }
    ],
    "link": "https://oracledispatch.com/2020/10/07/bristol-myers-squibb-company-nysebmy-stock-is-plummeting-here-is-why/",
    "id": "CBMia2h0dHBzOi8vb3JhY2xlZGlzcGF0Y2guY29tLzIwMjAvMTAvMDcvYnJpc3RvbC1teWVycy1zcXVpYmItY29tcGFueS1ueXNlYm15LXN0b2NrLWlzLXBsdW1tZXRpbmctaGVyZS1pcy13aHkv0gEA",
    "guidislink": false,
    "published": "Wed, 07 Oct 2020 14:16:21 GMT",
    "published_parsed": [
      2020,
      10,
      7,
      14,
      16,
      21,
      2,
      281,
      0
    ],
    "summary": "<a href=\"https://oracledispatch.com/2020/10/07/bristol-myers-squibb-company-nysebmy-stock-is-plummeting-here-is-why/\" target=\"_blank\">Bristol-Myers Squibb Company (NYSE:BMY) Stock is Plummeting, Here is Why</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Oracle Dispatch</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://oracledispatch.com/2020/10/07/bristol-myers-squibb-company-nysebmy-stock-is-plummeting-here-is-why/\" target=\"_blank\">Bristol-Myers Squibb Company (NYSE:BMY) Stock is Plummeting, Here is Why</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Oracle Dispatch</font>"
    },
    "source": {
      "href": "https://oracledispatch.com",
      "title": "The Oracle Dispatch"
    },
    "sub_articles": []
  },
  {
    "title": "Health Canada Approves ZEPOSIA\u00ae, an Oral Treatment for Relapsing Remitting Multiple Sclerosis - Investing News Network",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Health Canada Approves ZEPOSIA\u00ae, an Oral Treatment for Relapsing Remitting Multiple Sclerosis - Investing News Network"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://investingnews.com/news/biotech-investing/health-canada-approves-zeposia%C2%AE-an-oral-treatment-for-relapsing-remitting-multiple-sclerosis/"
      }
    ],
    "link": "https://investingnews.com/news/biotech-investing/health-canada-approves-zeposia%C2%AE-an-oral-treatment-for-relapsing-remitting-multiple-sclerosis/",
    "id": "CBMikwFodHRwczovL2ludmVzdGluZ25ld3MuY29tL25ld3MvYmlvdGVjaC1pbnZlc3RpbmcvaGVhbHRoLWNhbmFkYS1hcHByb3Zlcy16ZXBvc2lhJUMyJUFFLWFuLW9yYWwtdHJlYXRtZW50LWZvci1yZWxhcHNpbmctcmVtaXR0aW5nLW11bHRpcGxlLXNjbGVyb3Npcy_SAQA",
    "guidislink": false,
    "published": "Wed, 07 Oct 2020 14:43:24 GMT",
    "published_parsed": [
      2020,
      10,
      7,
      14,
      43,
      24,
      2,
      281,
      0
    ],
    "summary": "<a href=\"https://investingnews.com/news/biotech-investing/health-canada-approves-zeposia%C2%AE-an-oral-treatment-for-relapsing-remitting-multiple-sclerosis/\" target=\"_blank\">Health Canada Approves ZEPOSIA\u00ae, an Oral Treatment for Relapsing Remitting Multiple Sclerosis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing News Network</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://investingnews.com/news/biotech-investing/health-canada-approves-zeposia%C2%AE-an-oral-treatment-for-relapsing-remitting-multiple-sclerosis/\" target=\"_blank\">Health Canada Approves ZEPOSIA\u00ae, an Oral Treatment for Relapsing Remitting Multiple Sclerosis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing News Network</font>"
    },
    "source": {
      "href": "https://investingnews.com",
      "title": "Investing News Network"
    },
    "sub_articles": []
  },
  {
    "title": "US congressional leaders attack high pharma company prices - The BMJ",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "US congressional leaders attack high pharma company prices - The BMJ"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.bmj.com/content/371/bmj.m3911"
      }
    ],
    "link": "https://www.bmj.com/content/371/bmj.m3911",
    "id": "CBMiKWh0dHBzOi8vd3d3LmJtai5jb20vY29udGVudC8zNzEvYm1qLm0zOTEx0gEA",
    "guidislink": false,
    "published": "Wed, 07 Oct 2020 14:41:48 GMT",
    "published_parsed": [
      2020,
      10,
      7,
      14,
      41,
      48,
      2,
      281,
      0
    ],
    "summary": "<a href=\"https://www.bmj.com/content/371/bmj.m3911\" target=\"_blank\">US congressional leaders attack high pharma company prices</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The BMJ</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.bmj.com/content/371/bmj.m3911\" target=\"_blank\">US congressional leaders attack high pharma company prices</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The BMJ</font>"
    },
    "source": {
      "href": "https://www.bmj.com",
      "title": "The BMJ"
    },
    "sub_articles": []
  },
  {
    "title": "Phase 3 CheckMate-816 Trial Meets Primary End Point in Resectable NSCLC - Cancer Network",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Phase 3 CheckMate-816 Trial Meets Primary End Point in Resectable NSCLC - Cancer Network"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.cancernetwork.com/view/phase-3-checkmate-816-trial-meets-primary-end-point-in-resectable-nsclc"
      }
    ],
    "link": "https://www.cancernetwork.com/view/phase-3-checkmate-816-trial-meets-primary-end-point-in-resectable-nsclc",
    "id": "CBMiamh0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvcGhhc2UtMy1jaGVja21hdGUtODE2LXRyaWFsLW1lZXRzLXByaW1hcnktZW5kLXBvaW50LWluLXJlc2VjdGFibGUtbnNjbGPSAQA",
    "guidislink": false,
    "published": "Wed, 07 Oct 2020 14:06:08 GMT",
    "published_parsed": [
      2020,
      10,
      7,
      14,
      6,
      8,
      2,
      281,
      0
    ],
    "summary": "<a href=\"https://www.cancernetwork.com/view/phase-3-checkmate-816-trial-meets-primary-end-point-in-resectable-nsclc\" target=\"_blank\">Phase 3 CheckMate-816 Trial Meets Primary End Point in Resectable NSCLC</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Cancer Network</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.cancernetwork.com/view/phase-3-checkmate-816-trial-meets-primary-end-point-in-resectable-nsclc\" target=\"_blank\">Phase 3 CheckMate-816 Trial Meets Primary End Point in Resectable NSCLC</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Cancer Network</font>"
    },
    "source": {
      "href": "https://www.cancernetwork.com",
      "title": "Cancer Network"
    },
    "sub_articles": []
  },
  {
    "title": "Around the nation: Trump issues executive order calling for better coordination of mental health services - The Daily Briefing",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Around the nation: Trump issues executive order calling for better coordination of mental health services - The Daily Briefing"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.advisory.com/daily-briefing/2020/10/07/around-the-nation"
      }
    ],
    "link": "https://www.advisory.com/daily-briefing/2020/10/07/around-the-nation",
    "id": "CBMiRGh0dHBzOi8vd3d3LmFkdmlzb3J5LmNvbS9kYWlseS1icmllZmluZy8yMDIwLzEwLzA3L2Fyb3VuZC10aGUtbmF0aW9u0gEA",
    "guidislink": false,
    "published": "Wed, 07 Oct 2020 14:56:34 GMT",
    "published_parsed": [
      2020,
      10,
      7,
      14,
      56,
      34,
      2,
      281,
      0
    ],
    "summary": "<a href=\"https://www.advisory.com/daily-briefing/2020/10/07/around-the-nation\" target=\"_blank\">Around the nation: Trump issues executive order calling for better coordination of mental health services</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Daily Briefing</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.advisory.com/daily-briefing/2020/10/07/around-the-nation\" target=\"_blank\">Around the nation: Trump issues executive order calling for better coordination of mental health services</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Daily Briefing</font>"
    },
    "source": {
      "href": "https://www.advisory.com",
      "title": "The Daily Briefing"
    },
    "sub_articles": []
  },
  {
    "title": "Global Eating Disorders (EDs) Market 2020-2027 Refreshing Trends || Major Giants \u2013 Omeros Corporation, KUHNIL, Sunovion Pharmaceuticals, Inc., Alkermes - re:Jerusalem",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Global Eating Disorders (EDs) Market 2020-2027 Refreshing Trends || Major Giants \u2013 Omeros Corporation, KUHNIL, Sunovion Pharmaceuticals, Inc., Alkermes - re:Jerusalem"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://rejerusalem.com/16976/global-eating-disorders-eds-market-2020-2027-refreshing-trends-major-giants-omeros-corporation-kuhnil-sunovion-pharmaceuticals-inc-alkermes/"
      }
    ],
    "link": "https://rejerusalem.com/16976/global-eating-disorders-eds-market-2020-2027-refreshing-trends-major-giants-omeros-corporation-kuhnil-sunovion-pharmaceuticals-inc-alkermes/",
    "id": "CBMiqgFodHRwczovL3JlamVydXNhbGVtLmNvbS8xNjk3Ni9nbG9iYWwtZWF0aW5nLWRpc29yZGVycy1lZHMtbWFya2V0LTIwMjAtMjAyNy1yZWZyZXNoaW5nLXRyZW5kcy1tYWpvci1naWFudHMtb21lcm9zLWNvcnBvcmF0aW9uLWt1aG5pbC1zdW5vdmlvbi1waGFybWFjZXV0aWNhbHMtaW5jLWFsa2VybWVzL9IBAA",
    "guidislink": false,
    "published": "Wed, 07 Oct 2020 14:09:21 GMT",
    "published_parsed": [
      2020,
      10,
      7,
      14,
      9,
      21,
      2,
      281,
      0
    ],
    "summary": "<a href=\"https://rejerusalem.com/16976/global-eating-disorders-eds-market-2020-2027-refreshing-trends-major-giants-omeros-corporation-kuhnil-sunovion-pharmaceuticals-inc-alkermes/\" target=\"_blank\">Global Eating Disorders (EDs) Market 2020-2027 Refreshing Trends || Major Giants \u2013 Omeros Corporation, KUHNIL, Sunovion Pharmaceuticals, Inc., Alkermes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">re:Jerusalem</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://rejerusalem.com/16976/global-eating-disorders-eds-market-2020-2027-refreshing-trends-major-giants-omeros-corporation-kuhnil-sunovion-pharmaceuticals-inc-alkermes/\" target=\"_blank\">Global Eating Disorders (EDs) Market 2020-2027 Refreshing Trends || Major Giants \u2013 Omeros Corporation, KUHNIL, Sunovion Pharmaceuticals, Inc., Alkermes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">re:Jerusalem</font>"
    },
    "source": {
      "href": "https://rejerusalem.com",
      "title": "re:Jerusalem"
    },
    "sub_articles": []
  },
  {
    "title": "New Report Projects Immunotherapy Drug Market to Reach $274.6 Billion by 2025 with CAGR of 11.0% - MENAFN.COM",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "New Report Projects Immunotherapy Drug Market to Reach $274.6 Billion by 2025 with CAGR of 11.0% - MENAFN.COM"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://menafn.com/1100919442/New-Report-Projects-Immunotherapy-Drug-Market-to-Reach-2746-Billion-by-2025-with-CAGR-of-110"
      }
    ],
    "link": "https://menafn.com/1100919442/New-Report-Projects-Immunotherapy-Drug-Market-to-Reach-2746-Billion-by-2025-with-CAGR-of-110",
    "id": "CBMiemh0dHBzOi8vbWVuYWZuLmNvbS8xMTAwOTE5NDQyL05ldy1SZXBvcnQtUHJvamVjdHMtSW1tdW5vdGhlcmFweS1EcnVnLU1hcmtldC10by1SZWFjaC0yNzQ2LUJpbGxpb24tYnktMjAyNS13aXRoLUNBR1Itb2YtMTEw0gEA",
    "guidislink": false,
    "published": "Wed, 07 Oct 2020 14:47:07 GMT",
    "published_parsed": [
      2020,
      10,
      7,
      14,
      47,
      7,
      2,
      281,
      0
    ],
    "summary": "<a href=\"https://menafn.com/1100919442/New-Report-Projects-Immunotherapy-Drug-Market-to-Reach-2746-Billion-by-2025-with-CAGR-of-110\" target=\"_blank\">New Report Projects Immunotherapy Drug Market to Reach $274.6 Billion by 2025 with CAGR of 11.0%</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MENAFN.COM</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://menafn.com/1100919442/New-Report-Projects-Immunotherapy-Drug-Market-to-Reach-2746-Billion-by-2025-with-CAGR-of-110\" target=\"_blank\">New Report Projects Immunotherapy Drug Market to Reach $274.6 Billion by 2025 with CAGR of 11.0%</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MENAFN.COM</font>"
    },
    "source": {
      "href": "https://menafn.com",
      "title": "MENAFN.COM"
    },
    "sub_articles": []
  },
  {
    "title": "Geron Corporation (NASDAQ:GERN) \u2013 Analysts\u2019 Revisions Show Sentiment Is Improving - Stocks Register",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Geron Corporation (NASDAQ:GERN) \u2013 Analysts\u2019 Revisions Show Sentiment Is Improving - Stocks Register"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://stocksregister.com/2020/10/07/geron-corporation-nasdaqgern-analysts-revisions-show-sentiment-is-improving-2/"
      }
    ],
    "link": "https://stocksregister.com/2020/10/07/geron-corporation-nasdaqgern-analysts-revisions-show-sentiment-is-improving-2/",
    "id": "CBMidGh0dHBzOi8vc3RvY2tzcmVnaXN0ZXIuY29tLzIwMjAvMTAvMDcvZ2Vyb24tY29ycG9yYXRpb24tbmFzZGFxZ2Vybi1hbmFseXN0cy1yZXZpc2lvbnMtc2hvdy1zZW50aW1lbnQtaXMtaW1wcm92aW5nLTIv0gF4aHR0cHM6Ly9zdG9ja3NyZWdpc3Rlci5jb20vMjAyMC8xMC8wNy9nZXJvbi1jb3Jwb3JhdGlvbi1uYXNkYXFnZXJuLWFuYWx5c3RzLXJldmlzaW9ucy1zaG93LXNlbnRpbWVudC1pcy1pbXByb3ZpbmctMi9hbXAv",
    "guidislink": false,
    "published": "Wed, 07 Oct 2020 14:30:04 GMT",
    "published_parsed": [
      2020,
      10,
      7,
      14,
      30,
      4,
      2,
      281,
      0
    ],
    "summary": "<a href=\"https://stocksregister.com/2020/10/07/geron-corporation-nasdaqgern-analysts-revisions-show-sentiment-is-improving-2/\" target=\"_blank\">Geron Corporation (NASDAQ:GERN) \u2013 Analysts\u2019 Revisions Show Sentiment Is Improving</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stocks Register</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://stocksregister.com/2020/10/07/geron-corporation-nasdaqgern-analysts-revisions-show-sentiment-is-improving-2/\" target=\"_blank\">Geron Corporation (NASDAQ:GERN) \u2013 Analysts\u2019 Revisions Show Sentiment Is Improving</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stocks Register</font>"
    },
    "source": {
      "href": "https://stocksregister.com",
      "title": "Stocks Register"
    },
    "sub_articles": []
  },
  {
    "title": "Arthritic Therapeutic Market Size Estimation, Outbreak Impact Analysis, Key Insights and Application By 2027 - openPR",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Arthritic Therapeutic Market Size Estimation, Outbreak Impact Analysis, Key Insights and Application By 2027 - openPR"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.openpr.com/news/2151613/arthritic-therapeutic-market-size-estimation-outbreak-impact"
      }
    ],
    "link": "https://www.openpr.com/news/2151613/arthritic-therapeutic-market-size-estimation-outbreak-impact",
    "id": "CBMiYGh0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8yMTUxNjEzL2FydGhyaXRpYy10aGVyYXBldXRpYy1tYXJrZXQtc2l6ZS1lc3RpbWF0aW9uLW91dGJyZWFrLWltcGFjdNIBX2h0dHBzOi8vd3d3Lm9wZW5wci5jb20vYW1wLzIxNTE2MTMvYXJ0aHJpdGljLXRoZXJhcGV1dGljLW1hcmtldC1zaXplLWVzdGltYXRpb24tb3V0YnJlYWstaW1wYWN0",
    "guidislink": false,
    "published": "Wed, 07 Oct 2020 14:34:00 GMT",
    "published_parsed": [
      2020,
      10,
      7,
      14,
      34,
      0,
      2,
      281,
      0
    ],
    "summary": "<a href=\"https://www.openpr.com/news/2151613/arthritic-therapeutic-market-size-estimation-outbreak-impact\" target=\"_blank\">Arthritic Therapeutic Market Size Estimation, Outbreak Impact Analysis, Key Insights and Application By 2027</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">openPR</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.openpr.com/news/2151613/arthritic-therapeutic-market-size-estimation-outbreak-impact\" target=\"_blank\">Arthritic Therapeutic Market Size Estimation, Outbreak Impact Analysis, Key Insights and Application By 2027</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">openPR</font>"
    },
    "source": {
      "href": "https://www.openpr.com",
      "title": "openPR"
    },
    "sub_articles": []
  },
  {
    "title": "Rheumatoid Arthritis Drugs Market Research Growth by Manufacturers, Regions, Type and Application, Forecast Analysis to 2025 - Express Journal",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Rheumatoid Arthritis Drugs Market Research Growth by Manufacturers, Regions, Type and Application, Forecast Analysis to 2025 - Express Journal"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.express-journal.com/rheumatoid-arthritis-drugs-market-215556/"
      }
    ],
    "link": "https://www.express-journal.com/rheumatoid-arthritis-drugs-market-215556/",
    "id": "CBMiSWh0dHBzOi8vd3d3LmV4cHJlc3Mtam91cm5hbC5jb20vcmhldW1hdG9pZC1hcnRocml0aXMtZHJ1Z3MtbWFya2V0LTIxNTU1Ni_SAUxodHRwczovL3d3dy5leHByZXNzLWpvdXJuYWwuY29tL3JoZXVtYXRvaWQtYXJ0aHJpdGlzLWRydWdzLW1hcmtldC0yMTU1NTYvYW1w",
    "guidislink": false,
    "published": "Wed, 07 Oct 2020 14:16:35 GMT",
    "published_parsed": [
      2020,
      10,
      7,
      14,
      16,
      35,
      2,
      281,
      0
    ],
    "summary": "<a href=\"https://www.express-journal.com/rheumatoid-arthritis-drugs-market-215556/\" target=\"_blank\">Rheumatoid Arthritis Drugs Market Research Growth by Manufacturers, Regions, Type and Application, Forecast Analysis to 2025</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Express Journal</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.express-journal.com/rheumatoid-arthritis-drugs-market-215556/\" target=\"_blank\">Rheumatoid Arthritis Drugs Market Research Growth by Manufacturers, Regions, Type and Application, Forecast Analysis to 2025</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Express Journal</font>"
    },
    "source": {
      "href": "https://www.express-journal.com",
      "title": "Express Journal"
    },
    "sub_articles": []
  },
  {
    "title": "Borough Park Orthodox Jewish Community Protests New Restrictions - New York City, NY Patch",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Borough Park Orthodox Jewish Community Protests New Restrictions - New York City, NY Patch"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://patch.com/new-york/new-york-city/borough-park-orthodox-jewish-community-protests-new-restrictions"
      }
    ],
    "link": "https://patch.com/new-york/new-york-city/borough-park-orthodox-jewish-community-protests-new-restrictions",
    "id": "CAIiEDndaOMfflKeKwAQNq_H3XwqGQgEKhAIACoHCAowvr__CjDKhPkCMLSo6AU",
    "guidislink": false,
    "published": "Wed, 07 Oct 2020 14:35:00 GMT",
    "published_parsed": [
      2020,
      10,
      7,
      14,
      35,
      0,
      2,
      281,
      0
    ],
    "summary": "<a href=\"https://patch.com/new-york/new-york-city/borough-park-orthodox-jewish-community-protests-new-restrictions\" target=\"_blank\">Borough Park Orthodox Jewish Community Protests New Restrictions</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">New York City, NY Patch</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://patch.com/new-york/new-york-city/borough-park-orthodox-jewish-community-protests-new-restrictions\" target=\"_blank\">Borough Park Orthodox Jewish Community Protests New Restrictions</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">New York City, NY Patch</font>"
    },
    "source": {
      "href": "https://patch.com",
      "title": "New York City, NY Patch"
    },
    "sub_articles": []
  },
  {
    "title": "Tending News | Global Liver Cirrhosis Therapeutics Market Growth Outlook, Key Procurement Criteria and Geographical Analysis by 2025 (Covid-19 Impact Analysis)| Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck, Roche - TechnoWeekly",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Tending News | Global Liver Cirrhosis Therapeutics Market Growth Outlook, Key Procurement Criteria and Geographical Analysis by 2025 (Covid-19 Impact Analysis)| Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck, Roche - TechnoWeekly"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://technoweekly.com/news/34594/tending-news-global-liver-cirrhosis-therapeutics-market-growth-outlook-key-procurement-criteria-and-geographical-analysis-by-2025-covid-19-impact-analysis-gilead-sciences-glaxosmithkline-johns/"
      }
    ],
    "link": "https://technoweekly.com/news/34594/tending-news-global-liver-cirrhosis-therapeutics-market-growth-outlook-key-procurement-criteria-and-geographical-analysis-by-2025-covid-19-impact-analysis-gilead-sciences-glaxosmithkline-johns/",
    "id": "CBMi5QFodHRwczovL3RlY2hub3dlZWtseS5jb20vbmV3cy8zNDU5NC90ZW5kaW5nLW5ld3MtZ2xvYmFsLWxpdmVyLWNpcnJob3Npcy10aGVyYXBldXRpY3MtbWFya2V0LWdyb3d0aC1vdXRsb29rLWtleS1wcm9jdXJlbWVudC1jcml0ZXJpYS1hbmQtZ2VvZ3JhcGhpY2FsLWFuYWx5c2lzLWJ5LTIwMjUtY292aWQtMTktaW1wYWN0LWFuYWx5c2lzLWdpbGVhZC1zY2llbmNlcy1nbGF4b3NtaXRoa2xpbmUtam9obnMv0gEA",
    "guidislink": false,
    "published": "Wed, 07 Oct 2020 14:04:00 GMT",
    "published_parsed": [
      2020,
      10,
      7,
      14,
      4,
      0,
      2,
      281,
      0
    ],
    "summary": "<a href=\"https://technoweekly.com/news/34594/tending-news-global-liver-cirrhosis-therapeutics-market-growth-outlook-key-procurement-criteria-and-geographical-analysis-by-2025-covid-19-impact-analysis-gilead-sciences-glaxosmithkline-johns/\" target=\"_blank\">Tending News | Global Liver Cirrhosis Therapeutics Market Growth Outlook, Key Procurement Criteria and Geographical Analysis by 2025 (Covid-19 Impact Analysis)| Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck, Roche</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TechnoWeekly</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://technoweekly.com/news/34594/tending-news-global-liver-cirrhosis-therapeutics-market-growth-outlook-key-procurement-criteria-and-geographical-analysis-by-2025-covid-19-impact-analysis-gilead-sciences-glaxosmithkline-johns/\" target=\"_blank\">Tending News | Global Liver Cirrhosis Therapeutics Market Growth Outlook, Key Procurement Criteria and Geographical Analysis by 2025 (Covid-19 Impact Analysis)| Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck, Roche</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TechnoWeekly</font>"
    },
    "source": {
      "href": "https://technoweekly.com",
      "title": "TechnoWeekly"
    },
    "sub_articles": []
  },
  {
    "title": "Cytotoxic Drugs Market Future Scope Competitive Analysis and Revenue till 2025 - Eurowire",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Cytotoxic Drugs Market Future Scope Competitive Analysis and Revenue till 2025 - Eurowire"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://eurowire.co/uncategorized/33527/cytotoxic-drugs-market-future-scope-competitive-analysis-and-revenue-till-2025/"
      }
    ],
    "link": "https://eurowire.co/uncategorized/33527/cytotoxic-drugs-market-future-scope-competitive-analysis-and-revenue-till-2025/",
    "id": "CBMid2h0dHBzOi8vZXVyb3dpcmUuY28vdW5jYXRlZ29yaXplZC8zMzUyNy9jeXRvdG94aWMtZHJ1Z3MtbWFya2V0LWZ1dHVyZS1zY29wZS1jb21wZXRpdGl2ZS1hbmFseXNpcy1hbmQtcmV2ZW51ZS10aWxsLTIwMjUv0gEA",
    "guidislink": false,
    "published": "Wed, 07 Oct 2020 14:29:00 GMT",
    "published_parsed": [
      2020,
      10,
      7,
      14,
      29,
      0,
      2,
      281,
      0
    ],
    "summary": "<a href=\"https://eurowire.co/uncategorized/33527/cytotoxic-drugs-market-future-scope-competitive-analysis-and-revenue-till-2025/\" target=\"_blank\">Cytotoxic Drugs Market Future Scope Competitive Analysis and Revenue till 2025</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Eurowire</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://eurowire.co/uncategorized/33527/cytotoxic-drugs-market-future-scope-competitive-analysis-and-revenue-till-2025/\" target=\"_blank\">Cytotoxic Drugs Market Future Scope Competitive Analysis and Revenue till 2025</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Eurowire</font>"
    },
    "source": {
      "href": "https://eurowire.co",
      "title": "Eurowire"
    },
    "sub_articles": []
  },
  {
    "title": "Is Kinase Inhibitors Market in Trending Or Not? Know More About Notable Leading Plays Profiles And More - Eurowire",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Is Kinase Inhibitors Market in Trending Or Not? Know More About Notable Leading Plays Profiles And More - Eurowire"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://eurowire.co/uncategorized/33258/is-kinase-inhibitors-market-in-trending-or-not-know-more-about-notable-leading-plays-profiles-and-more/"
      }
    ],
    "link": "https://eurowire.co/uncategorized/33258/is-kinase-inhibitors-market-in-trending-or-not-know-more-about-notable-leading-plays-profiles-and-more/",
    "id": "CBMijwFodHRwczovL2V1cm93aXJlLmNvL3VuY2F0ZWdvcml6ZWQvMzMyNTgvaXMta2luYXNlLWluaGliaXRvcnMtbWFya2V0LWluLXRyZW5kaW5nLW9yLW5vdC1rbm93LW1vcmUtYWJvdXQtbm90YWJsZS1sZWFkaW5nLXBsYXlzLXByb2ZpbGVzLWFuZC1tb3JlL9IBAA",
    "guidislink": false,
    "published": "Wed, 07 Oct 2020 14:16:00 GMT",
    "published_parsed": [
      2020,
      10,
      7,
      14,
      16,
      0,
      2,
      281,
      0
    ],
    "summary": "<a href=\"https://eurowire.co/uncategorized/33258/is-kinase-inhibitors-market-in-trending-or-not-know-more-about-notable-leading-plays-profiles-and-more/\" target=\"_blank\">Is Kinase Inhibitors Market in Trending Or Not? Know More About Notable Leading Plays Profiles And More</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Eurowire</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://eurowire.co/uncategorized/33258/is-kinase-inhibitors-market-in-trending-or-not-know-more-about-notable-leading-plays-profiles-and-more/\" target=\"_blank\">Is Kinase Inhibitors Market in Trending Or Not? Know More About Notable Leading Plays Profiles And More</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Eurowire</font>"
    },
    "source": {
      "href": "https://eurowire.co",
      "title": "Eurowire"
    },
    "sub_articles": []
  }
]